Related Experiment Video
Updated: Aug 11, 2026
06:51
Ovariectomy and 17β-estradiol Replacement in Rats and Mice: A Visual Demonstration
Published on: June 7, 2012
Pharmacokinetics of ethynyl estradiol: a current view
Contraception
|July 1, 1985
Summary
Accurate ethynyl estradiol pharmacokinetics are challenging due to sampling, measurement, metabolism, and circulation issues. This study reviews methods to obtain reliable pharmacokinetic data and provides best estimates for key parameters.
Area of Science:
- Pharmacokinetics and Drug Metabolism
- Endocrinology
- Pharmaceutical Sciences
Background:
- Ethynyl estradiol pharmacokinetic parameters show significant variability in reported values.
- Challenges include limited sampling, low plasma concentrations, extensive metabolism, distribution, and enterohepatic circulation.
- Accurate data acquisition is complicated by these factors.
Purpose of the Study:
- To discuss challenges in obtaining reliable ethynyl estradiol pharmacokinetic data.
- To review techniques for evaluating pharmacokinetic parameters.
- To provide best estimates for ethynyl estradiol pharmacokinetic parameters based on literature.
Main Methods:
- Literature review of pharmacokinetic studies on ethynyl estradiol.
- Discussion of analytical techniques for plasma level measurement.
- Analysis of methods for determining optimal sampling times and frequencies.
Main Results:
- Identified key factors contributing to discrepancies in pharmacokinetic parameters.
- Highlighted difficulties in quantitating parameters due to analytical and biological complexities.
- Presented a compilation of best estimates for various pharmacokinetic parameters.
Conclusions:
- Reliable ethynyl estradiol pharmacokinetic data requires careful consideration of sampling, measurement, and metabolic factors.
- Standardized methods for parameter evaluation and sampling strategies are crucial.
- The provided parameter estimates serve as a valuable reference for future research and clinical applications.
Related Concept Videos
01:10Pharmacokinetics: Overview
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV) administration...
01:28Biopharmaceutics and Pharmacokinetics: Overview
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...
01:20Pharmacokinetic Models: Overview
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
01:30Measurement of Bioavailability: Pharmacokinetic Methods
Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
01:14Pharmacokinetic–Pharmacodynamic Relationship: Model Components
Pharmacokinetic-pharmacodynamic (PK–PD) modeling is essential in drug development and clinical pharmacology. It provides a quantitative framework to predict drug behavior and response over time. This approach integrates pharmacokinetics (PK), which describes the drug's absorption, distribution, metabolism, and excretion, with pharmacodynamics (PD), which characterizes the drug’s biological effects and mechanisms of action.The disposition kinetics of a drug determine its plasma...